While browsing the news, these are some of the stories that caught my attention:
- Clinical trials of two new drugs suggest they work better for advanced kidney cancer than standard treatments. One study involved the drug nivolumab (sold as Opdivo) and the other study demonstrated the effectiveness of cabozantinib (sold as Cometriq). Both studies were published in the New England Journal of Medicine.
- Scientists at Stanford University have re-engineered a virus into a safe vehicle for delivering vaccines and therapies directly where they are needed. Read more about this innovation in PNAS.
- According to a new study conducted by researchers at the Mayo Clinic, the genetic makeup of colon cancer tumors and survival rates differ by race. Researchers analyzed clinical trial data of more than 3000 white, black and Asian patients. Findings were published in the Journal of National Cancer Institute.
- A study led by scientists at the Institute of Cancer Research in London has revealed five new genetic variants associated with brain cancer. The study analyzed DNA from 5,637 people who had developed glioma, and compared it with 9,158 people without the disease. The results are published in Nature Communications.